Contemporary Use of Drug-eluting Stents. (Record no. 2858)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02086nam a22002657a 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 171205s20172017 xxu||||| |||| 00| 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1092-8464 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | Ovid MEDLINE(R) |
| 099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) | |
| PMID | 15913502 |
| 245 ## - TITLE STATEMENT | |
| Title | Contemporary Use of Drug-eluting Stents. |
| 251 ## - Source | |
| Source | Current Treatment Options in Cardiovascular Medicine. 7(1):35-46, 2005 May |
| 252 ## - Abbreviated Source | |
| Abbreviated source | Curr Treat Options Cardiovasc Med. 7(1):35-46, 2005 May |
| 253 ## - Journal Name | |
| Journal name | Current treatment options in cardiovascular medicine |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Year | 2005 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Manufacturer | FY2005 |
| 266 ## - Date added to catalog | |
| Date added to catalog | 2017-12-05 |
| 520 ## - SUMMARY, ETC. | |
| Abstract | Since the era of balloon angioplasty, stents have been a revolutionary advance in the treatment of severe coronary artery disease. However, one of the major limitations is in-stent restenosis. Although brachytherapy was found to be an effective treatment, the goal remains to develop a kind of stent that will not restenose. The emergence of drug-eluting stents provided a novel solution for the reduction of restenosis. The currently approved indication for drug-eluting stents by the US Food and Drug Administration is for discrete, de novo lesions in native vessels with reference vessel diameters of 2.5 to 3.5 mm. However, in the worldwide daily practice, there have been numerous off-label uses of drug-eluting stents, and their long-term follow-up and experience in more complex lesions are accumulating. This article reviews the current off-label uses of drug-eluting stents. The majority of the supporting data are from registry and observational studies, yet many studies are limited by small sample sizes. Therefore, large, prospective, randomized, double-blind, and controlled trials are definitely warranted to further support current practice. Nevertheless, the "real world" unrestricted uses of drug-eluting stents seem to be the current trend in the interventional field. |
| 546 ## - LANGUAGE NOTE | |
| Language note | English |
| 651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME | |
| Institution | MedStar Heart & Vascular Instituteon |
| 657 ## - INDEX TERM--FUNCTION | |
| Medline publication type | Journal Article |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Local Authors | Chu, William W |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Local Authors | Waksman, Ron |
| 790 ## - Authors | |
| All authors | Chu WW, Waksman R |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | Journal Article |
| Item type description | Article |
| Withdrawn status | Lost status | Damaged status | Not for loan | Collection | Home library | Current library | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MedStar Authors Catalog | MedStar Authors Catalog | 12/05/2017 | 15913502 | 15913502 | 12/05/2017 | 12/05/2017 | Journal Article |